Esclerosis peritoneal encapsulante en paciente en diálisis peritoneal domiciliaria
Álvarez González, Yanet; Bohorques Rodríguez, Raúl; López Marin, Laura.
Rev. cuba. med
; 59(1): e174, ene.-mar. 2020. graf
Artículo en Español | CUMED, LILACS | ID: biblio-1139043
Documentos relacionados
Vasculopathy plays an important role during the development and relapse of encapsulating peritoneal sclerosis with conventional peritoneal dialysis solutions.
Relationship between laparoscopic and microscopic findings of peritoneum in peritoneal dialysis patients.
Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan.
Epithelial-mesenchymal Transition of Peritoneal Mesothelial Cells Is Enhanced by M2c Macrophage Polarization.
A Successful Treatment of Encapsulating Peritoneal Sclerosis in an Adolescent Boy on Long-term Peritoneal Dialysis: A Case Report.
A case of encapsulated peritoneal sclerosis after peritoneal dialysis-related peritonitis.
Proteomic Characterization of Peritoneal Extracellular Vesicles in a Mouse Model of Peritoneal Fibrosis.
Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis.
Fibrosis of Peritoneal Membrane, Molecular Indicators of Aging and Frailty Unveil Vulnerable Patients in Long-Term Peritoneal Dialysis.
Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC-1α to reduce apoptosis in vitro and in vivo.